23andMe and 20 lung cancer advocacy organizations are working to improve lung cancer detection, risk reduction and care. 23andMe, the genetic health and biopharmaceutical company, has partnered with ...
In a new study, researchers investigated whether 25 rare gene variants known to be associated with inflammatory bowel disease (IBD) play a role in risk for African Americans. While the rare variant ...
Myriad Genetics, Inc. announced a study indicating that the use of its online screening tool, MyGeneHistory®, alongside a virtual education program, significantly increased the completion rates for ...
Research highlights how ExomeReveal RNA analysis resolves ambiguity around uncertain variants to enable more genetic disease diagnoses Ambry Genetics, a leader in clinical genomic testing, and a ...
Peer-reviewed publication examines the benefits of proactive exome reanalysis on diagnostic outcomes Ambry Genetics’ Patient for Life program is supported by a dedicated team of scientists who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results